Stephen A. Wald
Sunovion
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Stephen A. Wald.
Tetrahedron-asymmetry | 2000
Qun K. Fang; Zhengxu Han; Paul Grover; Donald W. Kessler; Chris H. Senanayake; Stephen A. Wald
Abstract A stereospecific method for the synthesis of enantiopure α-aminoketone from its corresponding α-hydroxy-ketone via the triflate intermediate is discussed. This strategy provides a rapid and efficient route for the preparation of either enantiomer of bupropion and its biologically active hydroxylated metabolite.
Tetrahedron Letters | 2001
James Wallace Hilborn; Zhi-Hui Lu; Alex R. Jurgens; Q.Kevin Fang; Paul Byers; Stephen A. Wald; Chris H. Senanayake
Abstract A convenient and chromatography-free synthesis for the enantiomers of fluoxetine and norfluoxetine is described. The synthesis relied on the use of the CBS reduction, and Hofman rearrangement to establish the key common intermediate 5 , and enrichment of optical purity of the final product by crystallization as the tartrate salt.
Tetrahedron Letters | 1999
Chris H. Senanayake; Kevin Q. Fang; Paul Grover; Roger P. Bakale; Charles P. Vandenbossche; Stephen A. Wald
Abstract Constrained aminoalcohol derived-ketoester or amides have provided a new entry for the production of enantiopure acid 1 for (S)-oxybutynin.
Tetrahedron Letters | 1998
Yaping Hong; Chris H. Senanayake; Tingjian Xiang; Charles P. Vandenbossche; Gerald J. Tanoury; Roger P. Bakale; Stephen A. Wald
Abstract Palladium-catalyzed selective amination by a primary amine in the presence of a secondary amine provided up to >99:1 selectivity with high yields.
Tetrahedron Letters | 2002
Derek Pflum; Dhileepkumar Krishnamurthy; Zhengxu Han; Stephen A. Wald; Chris H. Senanayake
Abstract Practical route technology for the preparation of ( S )-cetirizine·2HCl via diastereoselective organometallic addition to N - tert -butanesulfinyl aldimines is disclosed.
Tetrahedron Letters | 1997
Yaping Hong; Gerald J. Tanoury; H. Scott Wilkinson; Roger P. Bakale; Stephen A. Wald; Chris H. Senanayake
Abstract Palladium-catalyzed selective amination of 4-fluorobenzyl-2-chlorobenzimidazole with 4-aminopiperidine provided a simple solution for the norastemizole synthesis. Pd-catalyzed amination of other 2-chloro-1,3-Azole derivatives are exploited.
Tetrahedron Letters | 1997
Robert Hett; Qun Kevin Fang; Yun Gao; Yaping Hong; Hal T. Butler; Xiaoyi Nie; Stephen A. Wald
Abstract Enantioselective syntheses of all four stereoisomers of formoterol are accomplished using asymmetric catalytic borane reductions with chiral oxazaborolidines as reducing agents.
Tetrahedron Letters | 1998
Gerald J. Tanoury; Chris H. Senanayake; Robert Hett; Amy M. Kuhn; Donald W. Kessler; Stephen A. Wald
Abstract A palladium-catalyzed amination of triazolone 3 by piperazine 2 was used as the key step in an efficient synthesis of highly enantiomerically-pure hydroxyitraconazole isomers. Compound 2 (>99%ee) was prepared by reaction of an achiral phenol precursor with the corresponding dioxolyl tosylate (>99% ee), and 3 was made by alkylation of 6 with 7 (>99%ee).
Tetrahedron Letters | 1998
Robert Hett; Chris H. Senanayake; Stephen A. Wald
Abstract Several conformationally constrained oxazaborolidine catalysts have been evaluated in the reduction of ketone 1 . Readily accessible (1R, 2S) 1-amino-2-tetralol (BH) derived oxazaborolidine catalyst ( 6b ) proves to be the most effective and practical catalyst in the reduction of bromo-ketone 1 (96% ee).
Tetrahedron-asymmetry | 2001
Q.Kevin Fang; Paul Grover; Zhengxu Han; Fran X. McConville; Richard F. Rossi; Damase J. Olsson; Donald W. Kessler; Stephen A. Wald; Chris H. Senanayake
Abstract ( S )-1,4-Benzodioxan-2-carboxypiperazine ( S )- 2 , the key chiral intermediate for the synthesis of ( S )-doxazosin, was prepared utilizing two approaches: (i) enzymatic resolution of ethyl 1,4-benzodioxan-2-carboxylate with an esterase ( Serratia ) followed by amide formation; (ii) direct resolution of 1,4-benzodioxan-2-carboxypiperazine 2 with d -tartaric acid. An efficient process for the conversion of ( S )- 2 to ( S )-doxazosin mesylate was developed (80% yield, 99.9% e.e.).